Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825604 | SCV000966947 | likely pathogenic | Rare genetic deafness | 2018-03-07 | criteria provided, single submitter | clinical testing | The p.Ser130fs variant in POU4F3 has not been previously reported in individuals with hearing loss and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 130 and leads to a premature termination codon 43 amino a cids downstream. This termination codon occurs in the last exon and is likely to escape nonsense mediated decay resulting in a non-functional truncated protein. Heterozygous loss of function of the POU4F3 gene is strongly associated with he aring loss. In summary, although additional studies are required to fully establ ish its clinical significance, the p.Ser130fs variant is likely pathogenic. ACMG /AMP Criteria applied: PVS1_Strong, PM2 |